The kit uses the indirect immunofluorescence technique to incubate the control serum and the patient serum with the substrate immobilized on the slide. The antibody present in the sample will combine with the specific antigen in the substrate to form antigen-antibody complex, Then, the antibody was added to the anti-human IgG antibody conjugated with fluorescein to react with the antibody which had been bound antigen. The unbound antibody was washed away and the antigenic structure was observed by fluorescence microscopy after staining and sealing. On the green fluorescence intensity.
Product advantages
Independent research and development of the five series of fluorescent products, multi-standard multi-project optional;
The State Food and Drug Administration (CFDA) fully recognized the standardization of reagents, a good product component versatility;
First-class sensitivity and fluorescence background, so that the results of interpretation more clearly;
Safe and secure payments using Abraa safe trade systems 
\
